We'll see what larger investor interest BCDA attracts next week.
Should be entertaining as more accredited investors have one on one conversations with Peter Altman about BCDA's goals. If BCDA uplists to nasdaq after it's first audited annual 10k under the BCDA symbol, it would not surprise any of us. After all, gaining institutional investor interest is the track they are on.
http://www.businesswire.com/news/home/20170106005791/en/
Recent BCDA News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:30:48 PM
- BioCardia Regains Full Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 09/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:56 PM
- BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/09/2024 08:05:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/06/2024 11:45:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:42:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:41:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:40:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:40:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 10:01:22 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/30/2024 09:21:22 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/30/2024 09:20:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 12:00:10 PM
- BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 08/30/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/30/2024 04:15:13 AM
- Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 08/30/2024 12:09:56 AM
- BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 08/29/2024 12:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/29/2024 10:02:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 09:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 11:00:31 AM
- FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:57:35 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM